Abstract
The main goal of this study was to investigate the cardioprotective properties in terms of effects on cardiodynamics of perfluorocarbon emulsion (PFE) in ex vivo-induced ischemia–reperfusion injury of an isolated rat heart. The first part of the study aimed to determine the dose of 10% perfluoroemulsion (PFE) that would show the best cardioprotective effect in rats on ex vivo-induced ischemia–reperfusion injury of an isolated rat heart. Depending on whether the animals received saline or PFE, the animals were divided into a control or experimental group. They were also grouped depending on the applied dose (8, 12, 16 ml/kg body weight) of saline or PFE. We observed the huge changes in almost all parameters in the PFE groups in comparison with IR group without any pre-treatment. Calculated in percent, dp/dt max was the most changed parameter in group treated with 8 mg/kg, while the dp/dt min, SLVP, DLVP, HR, and CF were the most changed in group treated with 16 mg/kg 10 h before ischemia. The effects of 10% PFE are more pronounced if there is a longer period of time from application to ischemia, i.e., immediate application of PFE before ischemia (1 h) gave the weakest effects on the change of cardiodynamics of isolated rat heart. Therefore, the future of PFE use is in new indications and application methods, and PFE can also be referred to as antihypoxic and antiischemic blood substitute with mild membranotropic effects.
Similar content being viewed by others
Data availability
Data are available from the corresponding author upon reasonable request.
Code availability
NA.
References
Spahn D (1999) Blood substitutes artificial oxygen carriers: perfluorocarbon emulsions. Crit Care 5:R93–R97. https://doi.org/10.1186/cc364
Bilenko MV (1989) Ischemic and reperfusion injures of organs molecular mechanisms, ways of preventing and treatment. Medicine, Moscow (in Russian)
Blaisdell FW (1989) The reperfusion syndrome. Microcirc Endothelium Lymphatics 5:127–141
Ar’Rajab A, Dawidson I, Fabia R, (1996) Reperfusion injury. New Horiz 4:224–234
Lindsay TF, Luo XP, Lehotay DC, Rubin BB, Anderson M, Walker PM, Romaschin AD (1999) Ruptured abdominal aortic aneurysm, a “two-hit” ischemia/reperfusion injury: evidence from an analysis of oxidative products. J Vasc Surg 30:219–228. https://doi.org/10.1016/s0741-5214(99)70131-x
Vlasov TD, Smirnov DA, Nutfullina GM (2001) Adaptation of the rat small intestine to ischemia. Ross Fiziol Zh Im I M Sechenova 87:118–124 (in Russian)
Gennaro M, Mohan C, Ascer E (1996) Perfluorocarbon emulsion prevents eicoasanoid release in skeletal muscle ischemia and reperfusion. Cardiovasc Surg 4:399–404. https://doi.org/10.1016/0967-2109(95)00060-7
Memezawa H, Katayama Y, Shimizu J, Suzuki S, Kashiwagi F, Kamiya T, Terashi A (1990) Effects of fluosol-DA on brain edema, energy metabolites, and tissue oxygen content in acute cerebral ischemia. Adv Neurol 52:109–118
Mosca RS, Rohs TJ, Waterford RR, Childs KF, Brunsting LA, Bolling SF (1996) Perfluorocarbon supplementation and postischemic cardiac function. Surgery 120:197–204. https://doi.org/10.1016/s0039-6060(96)80288-1
Kubes P (1993) Ischemia-reperfusion in feline small intestine: a role for nitric oxide. Am J Physiol 264:G143–G149. https://doi.org/10.1152/ajpgi.1993.264.1.G143
Mathy-Hartert M, Krafft MP, Deby C, Deby-Dupont G, Meurisse M, Lamy M, Riess JG (1997) Effects of perfluorocarbon emulsions on cultured human endothelial cells. Artif Cells Blood Substit Immobil Biotechnol 25:563–575. https://doi.org/10.3109/10731199709117453
Speiss BD (2009) Perfluorocarbon emulsions as a promising technology: a review of tissue and vascular gas dynamics. J Appl Physiol 106:1444–1452. https://doi.org/10.1152/japplphysiol.90995.2008
Cohn C, Cushing M (2009) Oxygen Therapeutics: Perfluorocarbons and Blood Substitute Safety. Crit Care Clin 25:399–414. https://doi.org/10.1016/j.ccc.2008.12.007
Cabrales P, Ingaglietta M (2013) Blood substitutes: evolution from non-carrying to oxygen and gas carrying fluids. ASAIO J 59(4):337–354. https://doi.org/10.1097/MAT.0b013e318291fbaa
Verdin-Vasquez RC, Zepeda-Perez C, Ferra-Ferrer R, Chavez-Negrete A, Contreras F, Barroso-Aranda J (2006) Use of perftoran emulsion to decrease allogeneic blood transfusion in cardia surgery: clinical trail. Artif Cells Blood SubstitImmobil and Biotechnol 34:433–454. https://doi.org/10.1080/10731190600683969
Eckmann DM, Lomivorotov VN (2003) Microvascular gas embolization clearance following perfluorocarbon administration. J Appl Physiol 94:860–868. https://doi.org/10.1152/japplphysiol.00719.2002
Mayevskiy EI, Aksenova OG, Bogdanova LA, Moroz VV, Senina RY, Pushkin SY, Ivanitskiy GR (2001) Analysis of clinical and adverse effects during phase I and II clinical studies of perftoran. Russian Blood Banking Bulletin No.4
Maevsky E, Ivanitsky G, Bogdanova L, Axenova O, Karmen N, Zhiburt E, Senina R, Pushkin S, Maslennokov I, Orlov A (2005) Clincial results of perftoran application: present and future. Artif Cells Blood SubstitImmobil and Biotechnol 33:37–46. https://doi.org/10.1081/bio-200046654
Kozhura VL, Basarab DA, Timkina MI, Golubev AM, Reshetnyak VI, Moroz VV (2005) Reperfusion injury after critical intestinal ischemia and its correction with perfluorochemical emulsion “perfloran.” World J Gastroenterol 11:7084–7090. https://doi.org/10.3748/wjg.v11.i45.7084
Anthes Anthes E (2015) Evidence-based medicine: save blood, save lives. Nature 520:24–26. https://doi.org/10.1038/520024a
Frustaci A, Kajstura J, Chimenti C et al (2008) Myocardial cell death in human diabetes. Circ Res 87:1123–1132
Abutarboush R, Saha BK, Mullah SH, Arnaud FG, Haque A, Aligbe C, Pappas G, Auker CR, McCarron RM, Moon-Massat PF, Scultetus AH (2016) Cerebral microvascular and systemic effects following intravenous administration of the perfluorocarbon emulsion perftoran. J Funct Biomater 7(4):29. https://doi.org/10.3390/jfb7040029
Aimo A, Borrelli C, Giannoni A, Pastormerlo LE, Barison A, Mirizzi G, Emdin M, Passino C (2015) Cardioprotection by remote ischemic conditioning: mechanisms and clinical evidences. World J Cardiol 7:621–632. https://doi.org/10.4330/wjc.v7.i10.621
Bryan NS, Calvert JW, Elrod JW, Gundewar S, Ji SY, Lefer DJ (2007) Dietary nitrite supplementation protects against myocardial ischemia-reperfusion injury. Proc Natl Acad Sci USA 104:19144–19149. https://doi.org/10.1073/pnas.0706579104
D’ascenzo F, Cavallero E, Moretti C, Omede P, Sciuto F, Rahman IA, Bonser RS, Yunseok J, Wagner R, Freiberger T, Kunst G, Marber MS, Thielmann M, Ji B, Amr YM, Modena MG, Zoccai GB, Sheiban I, Gaita F (2012) Remote ischaemic preconditioning in coronary artery bypass surgery: a meta-analysis. Heart 98:1267–1271. https://doi.org/10.1136/heartjnl-2011-301551
Depre C, Vatner SF (2007) Cardioprotection in stunned and hibernating myocardium. Heart Fail Rev 12:307–317. https://doi.org/10.1007/s10741-007-9040-3
Downey JM (1990) Free radicals and their involvement during long-term myocardial ischemia and reperfusion. Annu Rev Physiol 52:487–504. https://doi.org/10.1146/annurev.ph.52.030190.002415
Endemann DH, Schiffrin EL (2004) Endothelial dysfunction. J Am Soc Nephrol 15:1983–1992. https://doi.org/10.1097/01.ASN.0000132474.50966.DA
Mangoni AA, Sherwood RA, Swift CG, Jackson SH (2002) Folic acid enhances endothelial function and reduces blood pressure in smokers: a randomized controlled trial. J Int Med 252:497–503. https://doi.org/10.1046/j.1365-2796.2002.01059.x
Lai WK, Kan MY (2015) Homocysteine-induced endothelial dysfunction. Ann Nutri Metab 67:1–12. https://doi.org/10.1159/000437098
Jacobsen DW (2000) Hyperhomocysteinemia and oxidative stress: time for a reality check? Arterioscler Thromb Vasc Biol 20:1182–1184. https://doi.org/10.1161/01.atv.20.5.1182
Czerska M, Mikołajewska K, Zielinski M, Gromadzinska J, Wasowicz W (2015) Today’s oxidative stress markers. Med Pr. 66:393–405. https://doi.org/10.13075/mp.5893.00137
Stoian I, Oros A, Moldoveanu E (1996) Apoptosis and free radicals. Biochem Mol Med 59:93–97. https://doi.org/10.1006/bmme.1996.0072
Djukic M, Ninkovic M, Jovanovic M (2008) Oxidative stress: clinical diagnostic significance. JMB 27:409–425. https://doi.org/10.2478/v10011-008-0024-1
Halliwell B (1994) Free radicals, antioxidants, and human diseases: curiosity, cause, or consequence? Lancet 344:721–724. https://doi.org/10.1016/s0140-6736(94)92211-x
Rahal A, Kumar A, Singh V, Yadav B, Tiwari R, Chakraborty S, Dhama K (2014) Oxidative stress, prooxidants, and antioxidants: the interplay. Biomed Res Int 2014:761264. https://doi.org/10.1155/2014/761264
Tak PP, Firestein GS (2001) NF-kappaB: a key role in inflammatory diseases. J Clin Invest 107:7–11. https://doi.org/10.1172/JCI11830
Hampton MB, Kettle AJ, Winterbourn CC (1998) Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood 92:3007–3017
Romero MM, Basile JI, Lopez B, Ritacco V, Barrera L, Sasiain Mdel C, Aleman M (2014) Outbreaks of Mycobacterium tuberculosis MDR strains differentially induce neutrophil respiratory burst involving lipid rafts, p38 MAPK and Syk. BMC Infect Dis 14:262. https://doi.org/10.1186/1471-2334-14-262
Bae YS, Kang SW, Seo MS, Baines IC, Tekle E, Chock PB, Rhee SG (1997) Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor- mediated tyrosine phosphorylation. J Biol Chem 272:217–221
Chandel NS, Maltepe E, Goldwasser E, Mathieu CE, Simon MC, Schumacker PT (1998) Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc Natl Acad Sci USA 95:11715–11720. https://doi.org/10.1073/pnas.95.20.11715
Chandel NS (2014) Mitochondria as signaling organelles. BMC Biol 12:34. https://doi.org/10.1186/1741-7007-12-34
Chandel NS, Trzyna WC, McClintock DS, Schumacker PT (2000) Role of oxidants in NF- kappa B activation and TNF-alpha gene transcription induced by hypoxia and endotoxin. J Immunol 165(2):1013–1021. https://doi.org/10.4049/jimmunol.165.2.1013
Valko M, Rhodes CJ, Moncol J, Izakovic M (2006) Free radicals metals and antioxidants in oxidative stress induced cancer. Chem Biol Interact 160:1–40. https://doi.org/10.1016/j.cbi.2005.12.009
Steinberg D (1997) Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem 272:20963–20966. https://doi.org/10.1074/jbc.272.34.20963
Anavi S, Ni Z, Tirosh O, Fedorova M (2014) Steatosis-induced proteins adducts with lipid peroxidation products and nuclear electrophilic stress in hepatocytes. Redox Biol 4C:158–168. https://doi.org/10.1016/j.redox.2014.12.009
Acknowledgements
This research was supported by the Faculty of Medical Sciences, University of Kragujevac.
Funding
NA.
Author information
Authors and Affiliations
Contributions
VLJ; SV: Conceptualization, Writing- Original draft preparation; SV; SB; EM; SSB; AS; PL; Validation, Visualization, and Methodology. VF; AT: Methodology. JJ; IS; TNT: Software. AO; TS: Data curation; Visualization. JJ; VLJ: Investigation. MK; ES; AM; TNT: Conceptualization, Writing-Original draft preparation, Supervision, and Writing-Reviewing and Editing.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Ethical approval
The study is approved by the Ethics Committee for Laboratory Animal Welfare of the Faculty of Medical Sciences, University of Kragujevac, Serbia.
Consent to participate
NA.
Consent for publication
NA.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Jakovljevic, V., Vorobyev, S., Bolevich, S. et al. Dose-dependent effects of perfluorocarbon-based blood substitute on cardiac function in myocardial ischemia–reperfusion injury. Mol Cell Biochem 477, 2773–2786 (2022). https://doi.org/10.1007/s11010-022-04479-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-022-04479-0